Search results for "Colitis"

showing 10 items of 483 documents

Effectiveness and safety of biologics in pediatric inflammatory boweldisease: Real-life data from the Sicilian Network

2019

Background: Biological therapies have modified the disease course of pediatric inflammatory bowel disease (IBD) and are routinely used in clinical practice. Our observational study aims to evaluate effectiveness and safety of biologics in IBD. Method: Clinical benefit and safety data of 93 children with IBD, receiving biologics (Infliximab – IFX, Adalimumab – ADA, Golimumab – GOL) from January 2013 to December 2017, were extracted from the cohort of the Sicilian Network of IBD. Results: Among 87 children aged 7–17 years (63 Crohn's disease [CD], 24 Ulcerative colitis [UC]), 101 out of 108 biologic treatments were considered. Evaluation of 74 biologic treatments in CD patients at 26, 52, 104…

Malemedicine.medical_specialtyYounger ageAdolescentBiologicEfficacyAnti-Inflammatory AgentsDiseaseInflammatory bowel diseaseInflammatory bowel disease03 medical and health sciences0302 clinical medicineCrohn DiseaseGastrointestinal AgentsInternal medicinemedicineHumansAdverse effectChildSicilyRetrospective StudiesBiological ProductsHepatologybusiness.industryGastroenterologyAdalimumabAntibodies MonoclonalBiologics; Child; Efficacy; Inflammatory bowel disease; Safetymedicine.diseaseUlcerative colitisReal life dataInfliximabTreatment Outcome030220 oncology & carcinogenesisCohort030211 gastroenterology & hepatologyObservational studyColitis UlcerativeFemaleSafetybusiness
researchProduct

Heat shock proteins and ulcerative colitis: The start of a new era?

2015

Malemedicine.medical_specialtybusiness.industryGastroenterologyMEDLINEmedicine.diseaseUlcerative colitisGastroenterologySurgeryHeat shock proteinInternal medicineHumansMedicineColitis UlcerativeFemaleHSP70 Heat-Shock ProteinsHSP90 Heat-Shock ProteinsIntestinal MucosaColitisbusinessPrecancerous ConditionsArab Journal of Gastroenterology
researchProduct

Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry

2021

Abstract Background and Aims The development programm UNIFI has shown promising results of ustekinumab in ulcerative colitis [UC] treatment which should be confirmed in clinical practice. We aimed to evaluate the durability, effectiveness, and safety of ustekinumab in UC in real life. Methods Patients included in the prospectively maintained ENEIDA registry, who received at least one intravenous dose of ustekinumab due to active UC [Partial Mayo Score [PMS]>2], were included. Clinical activity and effectiveness were defined based on PMS. Short-term response was assessed at Week 16. Results A total of 95 patients were included. At Week 16, 53% of patients had response [including 35% o…

Malemedicine.medical_specialtyustekinumabVedolizumab03 medical and health sciences0302 clinical medicineremissionColitis ulcerosaInternal medicineUstekinumabHumansMedicineProspective StudiesRegistriesInfusions IntravenousAdverse effectreal-world evidenceAcademicSubjects/MED00260ulcerative colitisTofacitinibresponsebiologybusiness.industryRemission InductionC-reactive proteinGastroenterologyGeneral MedicineMiddle Agedmedicine.diseaseUlcerative colitisDiscontinuation030220 oncology & carcinogenesisCohortbiology.proteindurabilityOriginal ArticleColitis UlcerativeFemaleMonoclonal antibodies030211 gastroenterology & hepatologyUstekinumabbusinessAnticossos monoclonalsmedicine.drug
researchProduct

Protection against 2,4,6-trinitrobenzenesulphonic acid-induced colonic inflammation in mice by the marine products bolinaquinone and petrosaspongioli…

2005

Proinflammatory mediators, namely eicosanoids, reactive oxygen and nitrogen species and cytokines, are clearly involved in the pathogenesis of intestinal bowel disease. bolinaquinone (BQ) and petrosaspongiolide M (PT), two marine products with potent anti-inflammatory action, have been shown to control the production of mediators in acute and chronic inflammatory processes. Hence, we have tested here the hypothesis that BQ and PT could ameliorate inflammation and oxidative stress parameters in 2,4,6-trinitrobenzenesulphonic acid (TNBS)-induced colitis in Balb/c mice. BQ and PT were given orally in doses of 10 or 20mg/kg/day. Treatment of the animals with BQ or PT at the highest dose signifi…

Malemedicine.medical_treatmentAnti-Inflammatory AgentsNitric Oxide Synthase Type IIInflammationNerve Tissue ProteinsPharmacologymedicine.disease_causeBiochemistryProinflammatory cytokinechemistry.chemical_compoundMiceSynaptotagminsDysideamedicineAnimalsOleanolic AcidPharmacologyMice Inbred BALB CMembrane GlycoproteinsbiologySuperoxideNitrotyrosineCalcium-Binding ProteinsInterleukinMembrane ProteinsColitisInflammatory Bowel DiseasesImmunohistochemistryNitric oxide synthasechemistryBiochemistryTrinitrobenzenesulfonic AcidCyclooxygenase 2Prostaglandin-Endoperoxide SynthasesSynaptotagmin IHeme Oxygenase (Decyclizing)biology.proteinmedicine.symptomNitric Oxide SynthaseSesquiterpenesOxidative stressHeme Oxygenase-1Prostaglandin EInterleukin-1Biochemical pharmacology
researchProduct

A non-redundant role for OX40 in the competitive fitness of Treg in response to IL-2.

2010

OX40 stimulation is known to enhance activation of effector T cells and to inhibit induction and suppressive function of Treg. Here we uncovered a novel role of OX40 in sustaining Treg competitive fitness in vivo, during repopulation of lymphopenic hosts and reconstitution of BM chimeras. Defective expansion of OX40-null Treg diminished their ability to suppress inflammation in a model of lymphopenia-driven colitis. OX40-mediated promotion of Treg fitness spanned beyond lymphopenic environments, as endogenous Treg in OX40-null mice showed decreased accumulation during thymic development, enhanced susceptibility to antibody-mediated depletion and defective turnover following thymectomy. In v…

Malemedicine.medical_treatmentImmunologyBlotting Westernchemical and pharmacologic phenomenaEndogenyInflammationSuppressor of Cytokine Signaling ProteinsT-Lymphocytes RegulatoryMiceSuppressor of Cytokine Signaling 1 ProteinLymphopeniaOX40; Treg; IL-2.medicineSTAT5 Transcription FactorImmunology and AllergyAnimalsOX40PhosphorylationReceptorSTAT5Cell ProliferationMice KnockoutbiologyEffectorCell growthSuppressor of cytokine signaling 1hemic and immune systemsReceptors OX40IL-2.ColitisFlow Cytometrycytokinescompetitive fitnessSpecific Pathogen-Free OrganismsThymectomyMice Inbred C57BLTregRadiation ChimeraImmunologybiology.proteinInterleukin-2costimulatory moleculesmedicine.symptomcompetitive fitness; costimulatory molecules; cytokines; treg
researchProduct

Computational flow dynamics in a geometric model of intussusceptive angiogenesis.

2009

Intussusceptive angiogenesis is a process that forms new blood vessels by the intraluminal division of a single blood vessel into two lumens. Referred to as nonsprouting or intussusceptive angiogenesis, this angiogenic process has been described in morphogenesis and chronic inflammation. Mechanical forces are relevant to the structural changes associated with intussusceptive angiogenesis because of the growing evidence that physiologic forces influence gene transcription. To provide a detailed analysis of the spatial distribution of physiologic shear stresses, we developed a 3D finite element model of the intraluminal intussusceptive pillar. Based on geometries observed in adult intussuscep…

Materials scienceAngiogenesisFlow (psychology)BiochemistryModels BiologicalArticleMicrocirculationMicemedicineShear strengthShear stressAnimalsComputer SimulationIntussusceptive angiogenesisMice Inbred BALB CNeovascularization PathologicComputational BiologyCell BiologyAnatomyColitisBiomechanical PhenomenaDisease Models Animalmedicine.anatomical_structureShear (geology)Trinitrobenzenesulfonic AcidBlood CirculationBiophysicsBlood Vesselssense organsStress MechanicalCardiology and Cardiovascular MedicineShear StrengthBlood vesselMicrovascular research
researchProduct

Oleuropein ameliorates acute colitis in mice.

2011

Oleuropein, the major secoiridoid in olive tree leaves, possesses a wide range of health promoting properties. It has recently been shown to exhibit anti-inflammatory activity. We have evaluated the effect of oleuropein on dextran sulfate sodium (DSS)-induced experimental colitis in mice in order to provide insight into its mechanisms of action. Oral administration of oleuropein notably attenuated the extent and severity of acute colitis while reducing neutrophil infiltration; production of NO, IL-1β, IL-6, and TNF-α; expression of iNOS, COX-2, and MMP-9; and the translocation of the NF-κB p65 subunit to the nucleus in colon tissue. In LPS-stimulated peritoneal macrophages, the oleuropein m…

MetaboliteIridoid GlucosidesAnti-Inflammatory AgentsChromosomal translocationPharmacologyNitric Oxidechemistry.chemical_compoundMiceOral administrationOleuropeinmedicineAnimalsIridoidsColitisAcute colitisPyransMice Inbred BALB CDextran SulfateInterleukinGeneral ChemistryPhenylethyl Alcoholmedicine.diseaseColitischemistryBiochemistryAcute DiseaseMacrophages PeritonealHydroxytyrosolCytokinesFemaleGeneral Agricultural and Biological SciencesJournal of agricultural and food chemistry
researchProduct

The METEOR Trial: The Burial of Methotrexate in Ulcerative Colitis?

2016

Meteor (satellite)medicine.medical_specialtyHepatologybusiness.industryGastroenterologymedicine.diseaseUlcerative colitisGastroenterology03 medical and health sciences0302 clinical medicineMethotrexate030220 oncology & carcinogenesisInternal medicinemedicineHumans030211 gastroenterology & hepatologyMethotrexateColitis UlcerativebusinessImmunosuppressive Agentsmedicine.drugGastroenterology
researchProduct

T-bet as a possible therapeutic target in autoimmune disease

2002

The prominent role of pro-inflammatory cytokines produced by T helper-1 (T(H1)) cells in regulating autoimmune responses in vitro and in vivo has been demonstrated. Recent observations of T cell polarisation by regulatory transcription factors--especially T-bet (T-box expressed in T cells)--raise the question of their influence in controlling autoimmune diseases. Here, the authors summarise recent observations of the role of T-bet in controlling chronic inflammatory and autoimmune diseases and discuss the implications of these findings for future therapeutic approaches.

Mice Inbred MRL lprTranscription GeneticTransgeneT cellCellular differentiationClinical BiochemistryMice TransgenicLymphocyte ActivationAutoimmune DiseasesInterferon-gammaMiceTh2 CellsCrohn DiseaseDrug DiscoverymedicineAnimalsLupus Erythematosus SystemicIL-2 receptorIntestinal MucosaMice KnockoutPharmacologyAutoimmune diseaseLupus erythematosusbusiness.industryZAP70Cell DifferentiationTh1 CellsColitisInflammatory Bowel Diseasesmedicine.diseaseCeliac DiseaseDisease Models Animalmedicine.anatomical_structureCTLA-4ImmunologyCytokinesMolecular MedicineT-Box Domain ProteinsbusinessTranscription FactorsExpert Opinion on Therapeutic Targets
researchProduct

Cytomegalovirus pneumonia in patients with inflammatory bowel disease: a systematic review

2012

Summary Background Inflammatory bowel disease (IBD) patients are at increased risk of cytomegalovirus (CMV) reactivation, and although CMV pneumonia may be a fatal disease in IBD patients, little information is available on this issue. The objectives of this study were to identify risk factors for the development of CMV pneumonia in IBD patients and to find useful information to better manage this potentially fatal complication. Methods A computerized search without language restrictions was conducted using PubMed and SCOPUS. An article was considered eligible for inclusion in the systematic review if it reported detailed data on patients with IBD presenting with pneumonia due to CMV. Resul…

Microbiology (medical)AdultMalePediatricsmedicine.medical_specialtyPneumonia ViralCongenital cytomegalovirus infectionCytomegalovirusHemophagocytic lymphohistiocytosisTachypneaInflammatory bowel diseaseInflammatory bowel diseaseRisk FactorsIntensive caremedicineHumanspneumoniapneumonia; Inflammatory bowel disease; CytomegalovirusCrohn's diseasesHemophagocytic lymphohistiocytosisbusiness.industryGeneral Medicinemedicine.diseaseInflammatory Bowel DiseasesUlcerative colitisSurgeryPneumoniaInfectious DiseasesUlcerative colitisCytomegalovirus InfectionsFemaleVirus Activationmedicine.symptomComplicationbusiness
researchProduct